In a recent article, “Epidermal Endocannabinoid System (EES) and Its Cosmetic Application,” published in the cosmetics division of MDPI publishing, Dr. Raymond Park and his co-authors identified the role of the Epidermal Endocannabinoid System as having potential therapeutic applications for inflammatory skin diseases, including allergic contact dermatitis, atopic dermatitis and psoriasis.
Various in vivo, in vitro and clinical studies have identified the endocannabinoid compounds that play the key role in skin health and Dr. Raymond Laboratories has worked on finding new ingredients(NEUROMIDE) for cosmetic skincare solutions. “We would like to develop cosmetic ingredients without possible psychological side effects of phytocannabinoid compounds when applied to the skin,” explained Dr. Park, “So we are focusing on a cannbinoid-mimicking compound called endocannabinomimetics which has no psychological side effects and will be safe for dermatological use.” Tested on a small group of healthy volunteers, endocannabinomimetics in Crystal Lamella MES formulation showed skin barrier recovery as well as significant increases in skin hydration immediately following one application.
The results of preliminary development and testing of endocannabinomimetics suggest that these compounds can be used for improving skin barrier functions, and can be a new candidate for new cosmeceutical ingredients for both sensitive and even in healthy skin.
A full version of the article containing the details of this research can be seen at https://www.mdpi.com/2079-9284/6/2/33/htm.
About Dr. Raymond Laboratories, Inc
Dr. Raymond Park has researched in skin barrier Science has helped many people who have suffered from skin barrier dysfunction. Dr. Raymond Labs has invented platform Skin Barrier Technology, named as Crystal Lamella MES (Micro-Encapsulation System) and have published more than fifty articles covering dermatological research. www.dermartology.com is the official site to introduce innovative skin barrier products.
